Boehringer Ingelheim Pledges USD 5 Million to WHO Foundation for Global Healthcare Advancement
Boehringer Ingelheim (BI), a leading German pharmaceutical company, has joined forces with the World Health...
Deals
Boehringer Ingelheim Partners with Circle Pharma to Develop First-in-Class Cyclin Inhibitor
Boehringer Ingelheim (BI), a leading German pharmaceutical company, has announced a research collaboration and license...
TenNor Therapeutics Secures USD 42.16 Million in Series E Financing for Antibacterial Pipeline
TenNor Therapeutics, a clinical-stage pharmaceutical company based in China, has announced the successful completion of...
Bayer AG and Meituan Deepen Partnership to Transform Skin Health Market in China
Bayer AG (ETR: BAYN), a leading German multinational pharmaceutical and life sciences company, has expanded...
Lundbeck Secures Rights to Bexicaserin with Acquisition of Longboard Pharmaceuticals
Lundbeck A/S (VIE: LUNA), a Danish pharmaceutical company, has announced its intention to acquire U.S.-based...
iRegene Therapeutics Secures Over USD 14 Million in Series B Financing to Advance Cell Therapies
iRegene Therapeutics, a Wuhan-based biotechnology company specializing in the development of AI-enhanced chemically induced cell...
Huawei Partners with Medical University Hospital to Boost Healthcare Innovation
The Affiliated Hospital of Xuzhou Medical University has entered into a comprehensive partnership with Huawei...
Akeso Biopharma Secures USD 250 Million in Share Placement, Bolstering Drug Development War chest
Akeso Biopharma (HKG: 9926), a biopharmaceutical company based in China, has declared the successful completion...
Sanofi Commences Negotiations with CD&R for Potential Sale of Opella Stake
Sanofi (EPA: SAN; NASDAQ: SNY) has initiated negotiations with private equity firm CD&R for the...
JD Healthcare and Genrix Bio Join Forces to Revolutionize Patient Care and Pharmacy Services
JD Healthcare, a subsidiary of China’s e-commerce juggernaut JD.com (NASDAQ: JD), has formed a strategic...
Eli Lilly & Co. Partners with Insitro to Leverage AI in Metabolic Disease Drug Development
Eli Lilly & Co. (NYSE: LLY), a stalwart of the US pharmaceutical industry, has inked...
Hetero and Gilead Sciences Partner to Expand Access to HIV Treatment in Low-Income Countries
Indian pharmaceutical company Hetero has announced a new partnership with US healthcare giant Gilead Sciences...
Eli Lilly Expands Collaboration with KeyBioscience to Develop Obesity Treatments Using DACRA Platform
Eli Lilly and Company (NYSE: LLY) has announced an extension of its collaboration with KeyBioscience...
XtalPi’s AI Platform XtalFold Secures Licensing Deal with Janssen Biotech, Enhancing Biologics Discovery
XtalPi (QuantumPharm, HKG: 2228) a leading AI-driven drug discovery firm based in Shenzhen and known...
Nona Biosciences Partners with OverT Bio to Develop Next-Generation Cell Therapies for Solid Tumors
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a...
Bill & Melinda Gates Foundation Invests $17 Million in CanSino Biologics’ Recombinant Polio Vaccine
The Bill & Melinda Gates Foundation has committed USD 17 million to support the development...
Beijing Aosaikang Pharmaceuticals Boosts Stake in US Subsidiary AskGene with RMB 220 Million Investment
Beijing Aosaikang Pharmaceutical Co., Ltd (SHE: 002755) has announced a capital injection of RMB 220...
HitGen Inc. Partners with Ablink Biotech to Develop Antibody-Oligonucleotide Conjugates
China-based HitGen Inc. (SHA: 688222) has entered into a partnership with compatriot firm Ablink Biotech...
Zephyrm Bioscience Limited Files for IPO on Hong Kong Stock Exchange
China-based Zephyrm Bioscience Limited, a biopharmaceutical company specializing in the development of novel pluripotent stem...
Ningbo Menovo Pharmaceutical Partners with Nanjing Huawe Medicine for High-End Product Development
Ningbo Menovo Pharmaceutical Co., Ltd (SHA: 603538) has entered into a strategic partnership with Nanjing...